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E-mail address: shimon@ifrec.osaka-u.ac.jp (S. SakA hypomorphic mutation of the gene encoding zeta-associated protein-70 (ZAP-70), a signaling mol-
ecule in T cells, produces autoimmune arthritis in mice under a microbially conventional condition
but not in a clean environment. The genetic anomaly alters thymic selection of self-reactive T cells
as well as natural regulatory T cells and their respective functions. Highly self-reactive polyclonal T
cells, including arthritogenic ones, thus produced by the thymus strongly recognize self-antigens
presented by antigen-presenting cells, stimulate them to up-regulate co-stimulatory molecules
and secrete cytokines that drive naïve self-reactive T cells to differentiate into autoimmune effector
Th17 cells. Administration of microbial products and activation of complement can facilitate the dif-
ferentiation, evoking clinically overt arthritis in a microbially clean environment. Furthermore,
mutation-dependent graded attenuation of T cell receptor signaling alters disease phenotypes and
the dependency of disease occurrence on the environment. These ﬁndings provide a model of
how genetic and environmental factors, in association, cause autoimmune diseases such as rheuma-
toid arthritis.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction
The cause of most autoimmune diseases, including rheumatoid
arthritis (RA), is multi-factorial; both genetic and environmental
factors contribute to their development. Yet, monogenic autoim-
mune diseases are instrumental in deciphering the mechanisms
of immunological self-tolerance and how it goes awry in autoim-
mune disease [1]. For example, mutations of the Foxp3 gene in
immune dysregulation polyendocrinopathy enteropathy X-linked
(IPEX) syndrome produces a variety of autoimmune diseases via
speciﬁcally affecting the development and function of natural reg-
ulatory T (Treg) cells [2]. In a similar vein, mutations of the autoim-
mune-regulator (Aire) gene are causative of autoimmune
polyendocrinopathy candidiasis ectodermal dystrophy (APECED)cal Societies. Published by Elsevier
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aguchi).syndrome, which is reportedly due to impaired central self-toler-
ance [3]. Both syndromes exhibit a similar spectrum of autoim-
mune diseases such as type 1 diabetes (T1D) and autoimmune
thyroiditis, suggesting that a variety of autoimmune diseases,
especially organ-speciﬁc ones, may share a common etiology and
pathogenesis. It is not clear, however, whether systemic autoim-
mune diseases such as RA should similarly develop as a result of
impaired central or peripheral mechanism of self-tolerance.
Here we discuss genetic anomalies of ZAP-70, which is a key
signal-transduction molecule immediately down-stream of the T
cell receptor (TCR) in T cells [4]. The anomalies result in a variety
of immune disorders ranging from complete T cell deﬁciency, IgE
hyperproduction, to autoimmune disease, depending on the locus
and the dose of the mutations. For example, a recessive point
mutation of the gene encoding the C-SH2 domain of ZAP-70 (this
W163C missense mutation is hereafter called skg ZAP-70 muta-
tion) results in spontaneous development of CD4+ T cell-mediated
chronic autoimmune arthritis in SKG mice [4,5]. Autoimmune
arthritis in SKG mice, which are on the BALB/c genetic background,
has the following immunological and clinical characteristics [5–7].
Joint swelling ﬁrst appears in the small ﬁnger joints, chronicallyB.V. Open access under CC BY-NC-ND license.
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Synovial inﬂammation (synovitis) is prevalent and characterized
by predominant inﬁltration of CD4+ T cells, which are able to adop-
tively transfer the disease into other mice. SKG arthritis also fre-
quently accompanies extra-articular lesions such as interstitial
lung disease (ILD), rheumatoid nodules, and vasculitides, and the
appearance of rheumatoid factor (RF) in the circulation. The pro-
gression of the arthritis is highly dependent on pro-inﬂammatory
cytokines such as TNF-a, IL-1, and IL-6, as in human RA. For exam-
ple, deﬁciencies of these cytokines, in particular IL-6, inhibits
arthritis development in these mice. In addition to the causal ge-
netic anomaly of ZAP-70, the polymorphism of the MHC gene sig-
niﬁcantly contributes to determining genetic susceptibility to
autoimmune arthritis in SKG mice. Furthermore, they spontane-
ously develop the disease in a microbially conventional environ-
ment, but not under a speciﬁc pathogen-free (SPF) condition. SKG
mice are therefore unique as a model of RA in that the primary ge-
netic anomaly is conﬁned to T cells, and not cells native to the
joint. Contributing to this ‘‘uniqueness’’ is that, although the mice
develop systemic autoimmune disease, it is predominantly mani-
fested in the joint and disease initiation requires the interaction
of both genetic and environmental factors.
Here, with this newly established monogenic model of autoim-
mune arthritis in mice, this article discusses how a genetic anom-
aly of a TCR-proximal signaling molecule alters thymic production
of pathogenic self-reactive T cells (including arthritogenic ones) as
well as Foxp3-expressing natural Treg cells that control them. It
addresses the conditions under which these arthritogenic T cells
undergo peripheral activation, proliferation, and differentiation
into effector T cells mediating autoimmune arthritis, and how
environmental factors modulate the processes. It also discusses
the relevance of the ﬁndings in this mouse model to the pathoge-
netic mechanism of RA and other autoimmune diseases in humans.Thymic stromal 
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Fig. 1. Altered T cell development and function in SKG mice. (A) Modulation of TCR
proximal signaling via skg ZAP-70 affects thymic selection of self-reactive T cells
and the generation/function of natural Treg cells. (B) TCR signal attenuation leads to
positive selection of highly self-reactive T cells and their escape from negative
selection, shifting TCR repertoire of conventional T cells and Treg cells to be more
self-reactive and thereby changing the spectrum of potential autoimmune diseases.2. Thymic production of arthritogenic T cells and natural Treg
cells, and their respective functions in SKG mice
The thymus has two main functions for establishing and sus-
taining immunological self-tolerance; i.e., negative selection (clo-
nal deletion) of self-reactive T cells and the production of natural
CD25+CD4+ Treg cells that speciﬁcally express the transcription
factor Foxp3 [2,8]. Brieﬂy, developing thymocytes expressing TCRs
weakly reactive with self-peptide/MHC (self-pMHC) ligands ex-
pressed on thymic stromal cells are positively selected to differen-
tiate into mature T cells, while those non-reactive with the self-
pMHC ligands are not selected (i.e., death by neglect). Those with
TCRs that react strongly with the ligands are negatively selected
(i.e., clonally deleted). Some T cells with relatively strong self-reac-
tivity, however, are driven to differentiate into Foxp3+CD25+CD4+
Treg cells. In the following section, we discuss how reduction in
TCR signal in SKG mice via mutated ZAP-70 affects the sensitivity
of developing T cells to these thymic selection processes, thereby
altering the TCR repertoire of conventional T cells and Treg cells,
in addition to impairing their respective functions [5,9].
2.1. Shift of TCR repertoire to higher self-reactivity by skg ZAP-70
mutation
Assuming that thymic positive selection of a developing T cell
(or evasion of ‘‘death by neglect’’) requires TCR signal intensity
above a certain threshold, only those T cells with skg ZAP-70 muta-
tion which bear high enough TCR afﬁnities for self-peptide/MHC li-
gands, hence high enough TCR-proximal signaling intensities to
compensate the signaling attenuation through the aberrant ZAP-
70, would be positively selected. Conversely, those T cells thatwould be normally negatively selected in ZAP-70-intact mice be-
cause of their too high afﬁnity for thymic self-pMHC ligands are
not deleted if they bear skg mutation because strong TCR signal
that would otherwise induce apoptosis is attenuated via skg ZAP-
70 [5,9]. These alterations in thymic T cell selection result in the
skewing of the whole T-cell repertoire towards higher self-reactiv-
ity, leading to the production of highly self-reactive T cells includ-
ing arthritogenic ones (Fig. 1). Indeed, SKG T cells are highly self-
reactive as illustrated by substantial increase in the number of
those T cells expressing particular Vb subfamilies which are reac-
tive with endogenous superantigen and therefore deleted in ZAP-
70-intact BALB/c mice [9]. The extent of this alteration in TCR rep-
ertoire depends on the degree of signal anomaly; for example, skg/
null mice, generated by mating SKG (skg/skg) mice with ZAP-70/
mice, suffer from more severe arthritis than SKG mice, whilst skg/+
mice (skg heterozygous) develop no arthritis albeit they have more
self-skewed TCR repertoire than +/+mice (wild-type). Functionally,
in a T cell-deﬁcient environment, SKG T cells exhibit more active
homeostatic proliferation than control ZAP-70-intact T cells via
strong recognition of self-pMHCs expressed by APCs [10]. Simi-
larly, in autologous mixed lymphocyte reaction (AMLR) (i.e.,
in vitro co-culture of CD4+ T cells with autologous splenic dendritic
cells [DCs]), SKG CD4+ T cells exhibit more vigorous proliferation
than ZAP-70-intact CD4+ T cells, while showing much less respon-
siveness than the latter to allo-antigen stimulation. This AMLR re-
sponse of SKG T cells can be inhibited by adding anti-class II MHC
blocking antibody to the culture [10].
Taken together, the SKG thymus is producing T cells with a vari-
ety of speciﬁcities for self-antigens as illustrated by polyclonal acti-
vation of self-reactive thymocytes and T cells in homeostatic
proliferation in vivo and AMLR in vitro. Such SKG CD4+ T cells
are strongly reactive with certain self-pMHC ligands physiologi-
cally presented by APCs in the periphery. The intensity of signal
emanating from their self-recognizing TCRs is sufﬁciently high to
enable their active proliferation despite the attenuated signal
reduction due to skg ZAP-70, which is contrary to their hypore-
sponsiveness to non-self-antigens (e.g., alloantigen). In addition,
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Fig. 2. A possible mechanism of SKG arthritis. SKG thymus produce self-reactive T
cells due to skg ZAP70 mutation (1) [5,9]. These T cells strongly recognize self-
antigen/MHC complexes displayed by APCs and become activated to express CD40L
(2), further leading to up-regulation of the expression of B7 (CD80/CD86) by APC via
CD40/CD40L interaction (3) and stimulating APC secretion of IL-6 (4) [10]. Activated
complement stimulates APCs to secrete IL-6 and T cell-derived GM-CSF augments
this process (5) [13]. IL-6 thus produced, together with tissue-produced TGF-b,
drives activated self-reactive T cells to differentiate into Th17 cells (6) [10]. CCL20
mainly secreted by stimulated synovial cells recruits Th17 cells to the inﬂammation
site in the joint (7) [12]. IFN-c and IL-4 inhibits Th17 cell differentiation and CCL20
production.
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mutation facilitates positive selection and abrogates negative
selection of certain self-reactive T cells such as arthritogenic T cells,
it fails in positive selection of other self-reactive T cells that would
be otherwise positively selected in ZAP-70-intact setting [9]. This
may alter genetic susceptibility to particular autoimmune diseases,
thereby rendering the host more susceptible to some autoimmune
diseases but resistant to others.
2.2. Thymic generation and peripheral function of Foxp3+ natural Treg
cells
Consistent with the shift observed in conventional T cells, the
skg ZAP-70 mutation also affects TCR repertoire formation and
function of Foxp3+ natural Treg cells [9]. In normal animals, natu-
ral Treg cells possess TCRs with higher afﬁnities for selecting self-
pMHC ligands expressed in the thymus than those of conventional
T cells; for example, T cells expressing those Vb subfamilies reac-
tive with endogenous superantigens are higher in ratio for Treg
cells than conventional T cells. The skg ZAP-70 mutation further
skews TCR repertoire of Treg cells towards much higher self-
reactivity than the repertoire of conventional T cells. The mutation
also impairs in vivo and in vitro suppressive function of natural
Foxp3+ Tregs since they require TCR stimulation to exert suppres-
sion [11]. For example, when SKG CD25CD4+ T cells are co-trans-
ferred with Foxp3+CD25+CD4+ Treg cells from non-arthritic SKG or
BALB/c mice to BALB/c nude mice, SKG Treg cells are much less
effective in inhibiting the development of arthritis [9]. The degree
of shift in TCR repertoire and impairment in suppressive activity
depends on the severity of signal reduction; that is, Foxp3+ Treg
cells from skg/-mice are more self-skewed and much less suppres-
sive in vitro than skg/skg Treg cells [9]. Although less effective than
normal, SKG Treg cells are exerting some degree of suppression on
self-reactive T cells because removal of Treg cells from SKG mice
not only exacerbates arthritis but also produces other autoimmune
diseases, which are different in disease spectrum from those
produced in BALB/c mice by Treg cell depletion [9]. In addition, a
single injection of cyclophosphamide, which reduces Foxp3+
natural Tregs as one of its immunological effects, is able to elicit
signiﬁcant incidence of mild arthritis in SPF SKG mice [7].
Taken together, arthritogenic T cells are inadequately controlled
by hypofunctional natural Treg cells in SKG mice; yet the balance
appears to be precarious and can be easily tipped towards autoim-
munity, for example, by enforcing T cells to proliferate in a T cell-
deﬁcient environment or by stimulating innate immune responses
via microbial products.3. Spontaneous differentiation of self-reactive T cells into
arthritogenic Th17 effector cells via modulation of APC function
It is a key feature of SKG arthritis model that thymic production
of potentially arthritogenic T cells and their persistence in the
periphery is not sufﬁcient for the occurrence of clinically evident
autoimmune arthritis [7]. The self-reactive T cells need to become
activated, expand, and differentiate into effector T cells that medi-
ate arthritis (Fig. 2). The main effector T cells in SKG arthritis are IL-
17-secreting Th17 cells as indicated by the following ﬁndings
[10,12,13]. IL-17-secreting cells, together with Th1 cells, are abun-
dant in the joints of arthritic SKG mice, but not of non-arthritic
ones. IL-17/ SKG mice fail to develop arthritis even after stimu-
lation of innate immunity (see below). IL-17/ SKG CD4+ T cells
are unable to adoptively transfer disease to normal mice. Further,
IL-6 is an absolute requirement for SKG arthritis because transfer
of IL-6/ SKG CD4+ T cells to IL-6/ RAG/ mice completely fails
to induce Th17 cells and arthritis, compared with the developmentof a large number of Th17 cells and the 100 per cent occurrence of
arthritis in IL-6+/+ RAG/ recipient mice transferred with IL-6+/+
SKG CD4+ T cells. In contrast with IL-6-deﬁciency, IFN-c-deﬁciency
exacerbates arthritis, as demonstrated by spontaneous arthritis
development in IFN-c-deﬁcient SKG mice even in an SPF environ-
ment [10]. Transfer of IFN-c-deﬁcient CD4+ SKG T cells induces
arthritis more easily than IFN-c-intact SKG CD4+ T cells, with a sig-
niﬁcant increase in the number of Th17 cells in RAG/ recipients.
In AMLR with peripheral CD4+ T cells or mature CD4+CD8 (CD4
single-positive [SP]) thymocytes from SKG mice, IL-6 is predomi-
nantly produced by DCs and not by responding CD4+ T cells/thy-
mocytes; TNF-a is produced by both CD4+ T cells/thymocytes
and DCs; and IL-17 is produced solely by CD4+ T cells and not by
CD4SP thymocytes [10]. Further, the in vitro production of IL-6,
TNF-a, and IL-17 in AMLR is markedly inhibited by anti-CD40L
blocking monoclonal antibody (mAb) and partially by anti-OX-
40L blocking mAb. Thus, the thymus-produced self-reactive T cells,
which become activated in the periphery via recognition of self-
pMHC complexes, stimulate APCs to up-regulate CD80/CD86 in a
CD40/CD40L interaction and thereby further activate themselves
to proliferate. Self-reactive T cells also stimulate APCs to secrete
IL-6 (and TNF-a, IL-1b, and IL-23), which, together with tissue-
derived TGF-b, drives at least some of naïve self-reactive CD4+ T
cells including arthritogenic ones to differentiate into Th17 cells
[10], as shown in other autoimmune models induced by exogenous
immunization with self-antigen (reviewed in Ref. [14]).
Th17 cells thus generated in a speciﬁc cytokine milieu migrate
to the joints in a chemokine-dependent fashion, as indicated by
predominant expression of the chemokine receptor CCR6 on SKG
Th17 cells [12]. Indeed, synoviocytes from arthritic joints of SKG
mice and RA patients produce a large amount of CCL20, the ligand
of CCR6, with a signiﬁcant correlation between the amounts of IL-
17 and CCL20 in RA joints. The CCL20 production is augmented
in vitro by IL-1b, IL-17, or TNF-a, and suppressed by IFN-c or IL-
4 [12]. Accordingly, administration of anti-CCR6 blocking mAb
inhibits the development of SKG arthritis signiﬁcantly.
Thus, SKG T cells are internally driven to differentiate into Th17
cells because of their high self-reactivity that stimulates APCs. In
other words, highly self-reactive SKG T cells form an internal cyto-
kine milieu for their own Th17 cell differentiation. IL-6 is essential
for the differentiation as indicated by complete inhibition of arthri-
tis development in IL-6-deﬁcient mice. Furthermore, homing of
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ment of Th17 cell-mediated autoimmune arthritis in SKG mice
and presumably in RA patients (Fig. 2). Of note, however, is that
spontaneous generation and peripheral presence of Th17 cells with
arthritogenic antigen speciﬁcities is not sufﬁcient to produce clin-
ically overt arthritis in SKG mice, as discussed below.
4. Precipitation of clinically overt arthritis by environmental
agents
In contrast with a high incidence of severe arthritis under a
microbially conventional condition, SKG mice raised in a clean
SPF environment fail to develop the disease [7]. When SKG mice
born in an SPF environment are transferred to a conventional con-
dition after weaning, they start to develop the disease, suggesting
that horizontally imposed environmental factors are responsible
for triggering the disease. Our attempts to evoke clinically overt
arthritis in SKG mice under an SPF condition have revealed several
biological substances with an arthritis-eliciting activity [7,10,13].
These include zymosan (a crude yeast cell wall extract), b-glucans
(glucose polymer b-1, 3-D-glucans), and mannan (poly-mannose).
A single intraperitoneal injection of each substance induces
arthritis in SPF SKG mice in a dose-dependent fashion. Polyino-
sinic-polycytidylic acid (Poly [I:C]), a double-stranded RNA charac-
teristic of some viruses, has also exhibited a mild arthritogenic
effect when injected every other day for 4 months [7]. These ﬁnd-
ings indicate that certain microbes, such as fungi, bacteria, and
viruses, may be able to evoke chronic autoimmune arthritis in
SKG mice.
The most plausible mechanism by which zymosan, b-glucans,
and mannan trigger autoimmune arthritis in SPF SKG mice is acti-
vation of self-reactive T cells via stimulating innate immunity,
rather than direct arthritogenic effect, which is usually transient,
mild, and absent with mannan treatment [7,10,13]. Zymosan in-
deed induces DC maturation via Toll-like receptor (TLR) 2 and 6,
upregulates DC expression of CD80/CD86, CD40, and class II
MHC, and stimulates DCs to secrete various cytokines including
IL-1, IL-6, IL-12, IL-23, and TNF-a. b-glucans, which are the main10                        102
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receptor. Laminarin or curdlan, a linear or branching form of b-
glucans, respectively, evokes SKG arthritis and the blockade of
Dectin-1 prevents disease development. Since zymosan is also an
activator of the alternative pathway of complement (C), and b-
glucan structure can be recognized by ﬁcolin-L, an initiator of the
lectin pathway of C-activation, these substances may also contrib-
ute to triggering SKG autoimmune disease via C-activation. Indeed,
a single injection of mannan, a prototypic activator of the lectin
pathway of C activation, is able to evoke arthritis efﬁciently in
SPF SKG mice [13]. Furthermore, C5a, a chief component of com-
plement activation, produced via all three complement pathways
(i.e., lectin, classical, and alternative) stimulates tissue resident
macrophages, but not DCs, to produce inﬂammatory cytokines
including IL-6, in synergy with TLR signaling. In addition, GM-CSF
secreted by activated T cells enhances IL-6 production by C5a-
stimulated macrophages in vitro. In vivo, C5a receptor (C5aR)
deﬁciency in SKG mice inhibits the differentiation/expansion of
Th17 cells after mannan or b-glucan treatment, and consequently
suppresses the development of arthritis [13].
Thus, a variety of microbial substances can augment Th17 cell
differentiation and expansion in SKG mice by stimulating DCs
and macrophages via TLR, Dectin-1, as well as C activation, thereby
precipitating overt autoimmune arthritis. This is a good example of
environmental agents playing a critical role in induction of autoim-
mune disease by activating innate immunity, rather than antigenic
mimicry of self-constituents. Furthermore, the degree of the con-
tribution of such environmental factors depends on the severity
of genetic anomaly, as illustrated by spontaneous development of
arthritis in skg/- mice even in an SPF condition without need for
stimulating innate immunity.5. Other ZAP-70 gene mutations in mice and humans
Many different mutations of the ZAP-70 gene in mice and
humans, with a variety of immunological phenotypes, have been
reported (Fig. 3). Some of these are brieﬂy discussed.618
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ZAP-70 mutant mice
In addition to the arthritis-causing skg mutation, other sponta-
neous or induced mutations of the ZAP-70 gene in mice result in a
variety of phenotypes including immunodeﬁciency, hyperproduc-
tion of IgE, and production of autoantibodies such as RF and anti-
DNA antibody, albeit without clinically overt arthritis [15–18].
The ST strain of mice with a mutation of highly conserved
DLAARN motif of ZAP-70 kinase domain (R464C) showed a com-
plete lack of CD4 and CD8SP thymocytes as well as CD4+ or CD8+
mature T cells in the periphery [15]. This developmental arrest of
thymocytes at the CD4+CD8+ (double-positive [DP]) stage is also
the case for mice homozygous for W504R mutation (designated
as mrtless mutation) affecting the kinase domain and reducing
ZAP-70 protein expression to a quarter of wild-type level [16]. An-
other mutation of the kinase domain, I367F (designated as mur-
dock), only showed mild reduction in the number of CD4+ T cells
[16]. However, when I367F mice were crossed with W504R mice,
resultant I367F/W504R mice showed compromised thymic selec-
tion and excessive production of IgE and anti-DNA autoantibodies.
Similar to SKG mice, YYAA mice with Y315A and Y319A muta-
tions, affecting an interdomain between C-terminal SH2 and the ki-
nase domain, showed partial immunodeﬁciency with impaired
thymic development of CD4SP, CD8SP, and Treg cells [17].
Although YYAA mice on the BALB/c genetic background, the same
background as SKG mice, produced RF after zymosan treatment,
they failed to develop clinically or pathologically evident autoim-
mune arthritis. Judging from milder increases of self-reactive Vb
subfamilies as well as less attenuated calcium response and TCR
signaling via phospho-Erk pathway in YYAA mice compared with
SKG mice, the YYAA mutation does not appear to attenuate ZAP-
70 signaling function as severely as the SKG mutation [17]. Fur-
thermore, comparison of the number of developing T cells between
I367F/W504R and YYAA mutations indicates that the former atten-
uates ZAP-70 signaling more severely than the latter or the skg
mutation (Fig. 3).
These ZAP-70 mutations suggest that the greater degree of sig-
nal reduction through altered ZAP-70, as in R464C or I367F/W504R
mutation, leads to a complete or severe T cell deﬁciency, whereas
milder attenuations of ZAP-70 signaling, as in skg or YYAA muta-
tion, result in a mild T-cell deﬁciency with a propensity to select
thymocytes with self-reactive TCR repertoire. In the latter case, a
particular degree of TCR signal reduction is able to produce a TCR
repertoire predominantly containing arthritogenic speciﬁcities as
seen in SKG mice (Fig. 3). Furthermore, since TCR signal attenua-
tion also affects Treg cell development and function (see above),
a particular mutation may additionally alter suppressive function
of Treg cells and thereby elicit hyper-IgE and autoimmunity as
seen in Foxp3 deﬁciency in humans. Thus, a variety of immune dis-
orders may develop depending on the degree of TCR signal reduc-
tion which affects the development, TCR repertoire formation, and
functions of conventional T cells as well as Treg cells.
5.2. ZAP-70 gene mutations in humans
In comparison to what we observe in mice, there are no reports
for human autoimmune arthritis that are associated with hypo-
morphic mutations of ZAP-70. However, there seems to be funda-
mental differences in the role of ZAP-70 in thymic development of
human and mouse T cells. In humans, loss-of-function mutations
of ZAP-70, mostly within the kinase domain, result in a complete
lack of CD8+ T cells and, unlike mice [19], with normal to increased
numbers of CD4+ T cells in the periphery [20–28]. This major dis-
crepancy between mice and humans can be attributed to high
expression of Syk in human DP thymocytes [29]. Syk and ZAP-70are the only members of Syk family kinases sharing similar domain
organization and shown to have some redundant functions when
expressed together. In mice, Syk is highly expressed at the early
developmental stages of thymocytes (DN1-DN3) and becomes
downregulated after pre-TCR signaling, while ZAP-70 is highly ex-
pressed after the DN4 stage of thymic development. However, in
humans, Syk continues to be high in the DP stage and is down-
regulated in the periphery [23,29]. Because of this overlapping
expressions of Syk and ZAP-70 in humans, and possibly due to
stronger association of Lck with CD4 than CD8 [30], CD4 lineage
selection may be rescued in human ZAP-70 deﬁciency. Consistent
with the down-modulation of Syk expression in peripheral T cells,
CD4+ T cells present in the peripheral compartment of patients
with ZAP-70 deﬁciency are defective in TCR signaling and therefore
unresponsive to anti-CD3 stimulation [23]. Because of the potential
of Syk to rescue ZAP-70 function in ZAP-70-deﬁcient CD4SP thy-
mocytes, the patients are likely protected from generating highly
self-reactive CD4SP thymocytes, hence from developing autoim-
mune arthritis and other autoimmune diseases. In any case, further
study is required to assess possible arthritogenic mutations of
other genes encoding other TCR signaling molecules, as discussed
below.
6. SKG autoimmune disease as a model of human RA
The mechanism of SKG arthritis discussed above has several
implications for RA in humans, in particular, how genetic anomaly
in the T cell compartment, not the joint, is able to cause autoim-
mune arthritis, how the T cell anomaly predominantly produces
autoimmune arthritis and not other autoimmune diseases, and
how genetic and environmental factors interact to induce RA.
6.1. RA as a systemic autoimmune disease
Like RA, SKG arthritis bears the following extra-articular man-
ifestations, which indicate a common basis for arthritis and ex-
tra-articular lesions [5,31]. First, SKG mice develop ILD
especially in microbially conventional environment [5]. Interest-
ingly, some of T cell clones established from arthritic joints pro-
duced not only arthritis but also ILD when they were transferred
to syngeneic T cell-deﬁcient nude mice, indicating their recogni-
tion of a common self-antigen expressed in the joint and the
lung [32]. As the clones also respond to MHC-matched APCs
from normal mice, they appear to recognize, in a MHC-restricted
fashion, a rather ubiquitously expressed self-antigen. Second,
SKG mice develop RF and also anti-cyclic citrullinated peptide
(anti-CCP) antibody when assessed by ELISA for human anti-
CCP antibody [6, and our unpublished data]. The development
of RF and anti-CCP autoantibody is not the consequence of
arthritis, but an effect of the SKG T cell anomaly, since both anti-
bodies develop in IL-6-deﬁcient SKG mice without arthritis or
Th17 cell development [6,10]. This suggests that the develop-
ment of these autoantibodies may be an independent parallel
event distinct from arthritis occurrence and perhaps due to an-
other type of inﬂammation elicited by SKG T cells distinct from
Th17 cells. These ﬁndings may provide some clues to the mech-
anism of ILD and autoantibody development in human RA.6.2. A common genetic basis between RA and other autoimmune
diseases
Depletion of Treg cells produces a variety of autoimmune dis-
eases depending on the genetic background of mice [9,33,34]. Treg
removal from BALB/c mice for example, predominantly induces
autoimmune gastritis and oophoritis with only a low incidence of
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arthritis development but reduced incidence and severity of gastri-
tis is observed [9]. In NOD mice, homozygous introduction of the
skg mutation inhibits T1D development. Instead, it induces arthri-
tis [9]. These changes in the spectrum of autoimmune diseases are
dependent on the dose of the mutation; i.e., mice heterozygous in
the mutation exhibit an intermediate incidence of each autoimmu-
nity between wild type mice and skg homozygotes. Thus, the de-
gree of the skg-induced impairment of T cell signaling changes
genetic predisposition to multiple autoimmune diseases through
altering the TCR repertoire of self-reactive T cells (Fig. 1). It renders
the host susceptible to some autoimmune diseases and, impor-
tantly, resistant to others even in heterozygotes. In addition, with
more severe reduction of TCR signaling and hence acquisition of
more self-skewed TCR repertoire, more systemic autoimmune dis-
eases such as RA tend to develop whereas incidence of organ-
localized ones such as T1D and autoimmune gastritis is reduced.
The skg mutation suggests that mutations of other loci of the
ZAP-70 gene or the genes encoding other signaling molecules espe-
cially at TCR proximal steps may well contribute to the develop-
ment of autoimmune arthritis (and other autoimmune diseases)
if the mutation reduces TCR proximal signal to the level as seen
in SKG T cells. In humans, there is accumulating evidence that
polymorphism of the PTPN22 gene, which encodes a hematopoi-
etic cell-speciﬁc protein tyrosine phosphatase, speciﬁcally contrib-
utes to the genetic risk of RA and other autoimmune diseases
including T1D, SLE, Addison’s disease, and autoimmune thyroid
disease [35–39]. This is the most signiﬁcant and reproducible asso-
ciation with RA other than the HLA gene [40]. Homozygotes of the
polymorphism are more susceptible to RA [36]. A recent study has
shown that this PTPN22 variant (R620W) is a gain-of-function mu-
tant, increasing phosphatase activity of the molecule and thereby
leading to reduction of TCR signaling and less IL-2 production by
T cells [41]. The tyrosine phophatase Lyp encoded by the PTPN2
gene interacts with various signaling molecules including ZAP-70
[42]. It is intriguing therefore to know whether the PTPN22
R620W variant affects thymic T cell selection and/or the develop-
ment or function of Treg cells as does the SKG mutation of ZAP-
70. Reduction of IL-2 may also impair homeostatic maintenance
of natural Treg cells, as neutralization of circulating IL-2 reduces
the number of Foxp3+CD25+CD4+ Treg cells and triggers organ-
speciﬁc autoimmune disease in genetically susceptible mice [43].
It is estimated that the polymorphism of the HLA gene consti-
tutes at least 30% of genetic contribution to RA development
[44]. Yet, it is still controversial whether a susceptible MHC mole-
cule binds a self-peptide targeted in RA or a peptide derived from
an arthritogenic microbe, or whether the polymorphism contrib-
utes to the thymic selection of a particular T-cell repertoire or
peripheral activation of arthritogenic T cells [45]. Interestingly, in
the linkage analysis of the genes determining the susceptibility
to arthritis in SKG mice, there is a signiﬁcant linkage with the H-
2 locus on chromosome 17, besides the skg locus on chromosome
1 [5]. The mice that develop arthritis even in an arthritis-resistant
microbially clean environment show much more frequent homo-
zygosity of the H-2d haplotype than heterozygosity. Homozygotes
of susceptible MHC haplotypes might more abundantly present
MHC-bound target self-peptides to developing T cells than hetero-
zygotes, thereby enhancing positive selection of arthritogenic T
cells and/or their activation in the periphery. Thus, modiﬁcation
of signaling on the T cell side and alteration of MHC binding of
self-peptides on the APC side can both determine the phenotype
of autoimmune disease (Fig. 1).
Collectively, alteration of TCR-proximal signaling due to genetic
anomalies or variations may contribute to determining genetic
susceptibility to a spectrum of autoimmune diseases, rendering
the host susceptible to some autoimmune diseases and at the sametime resistant to others. The PTPN22 R620W variant, for example,
might have such dual effects. Furthermore, as exempliﬁed by a
ZAP-70 anomaly in mice and the polymorphism of HLA and
PTPN22 in humans, many human autoimmune diseases including
RA may share a common genetic basis.
6.3. Contribution of environmental factors to the development of
autoimmune disease
There is epidemiological evidence that environmental factors play
signiﬁcant roles in the development of RA. However, identiﬁcation of
causative agents has remained elusive [31]. Various environmental
stimuli including viral infections are known to cause arthritis, yet
the disease is usually self-limiting [31]. Administration of zymosan
or b-glucan, for example, can indeed elicit in normal mice a transient
arthritis, which is not a T cell-mediated autoimmune disease [7]. In
contrast, a similar treatment can elicit chronic T cell-mediated auto-
immune arthritis in SKGmice. This is a clear illustration that the pen-
etrance of an autoimmune-causing genetic anomaly is strongly
inﬂuenced by environmental factors. Regarding SKG arthritis, the
modes of action of environmental agents in inducingdisease suggests
the following. First, synovial inﬂammation per se incited by environ-
mental agentsmay not be sufﬁcient to evoke chronic T cell-mediated
autoimmune arthritis unless one harbors potentially arthritogenic T
cells sufﬁcient in number and/or TCR speciﬁcity to mediate arthritis.
Second, one-time ‘‘hit-and-run’’ exposure to such agents may sufﬁce
to trigger chronic arthritis in thosewhoharbordormant arthritogenic
autoimmune T cells due to genetic anomaly or variation. In addition,
successful evoking of arthritis in SPF SKG mice by depleting natural
CD25+CD4+ Treg cells indicates that environmental insults that re-
duce Treg cells or affect their function can also trigger arthritis in
genetically susceptible individuals.
7. Conclusion and perspective
Autoimmune arthritis in SKG mice illustrates that a genetic de-
fect of T cells, but not the joint, can be a cause of T cell-mediated
autoimmune arthritis similar to human RA, and that clinical man-
ifestation of this genetic anomaly requires environmental stimuli.
Further genetic and immunologic analyses of SKG arthritis at each
step of the pathogenetic pathway from the ZAP-70 mutation,
through thymic generation of autoimmune T cells and natural Treg
cells, to activation, expansion, and differentiation of autoimmune
arthritogenic T cells in the periphery, will help to decipher how a
speciﬁc combination of genetic and environmental factors leads
to the development of RA as a systemic autoimmune disease. It will
also contribute to furthering our understanding of the etiology and
the mechanism of other T cell-mediated autoimmune diseases and
devising effective ways for their treatment and prevention.
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